4.7 Article

Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species

Journal

CELL DEATH AND DIFFERENTIATION
Volume 21, Issue 3, Pages 388-396

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2013.149

Keywords

mesenchymal stem cells; inducible nitric oxide synthase; indoleamine 2; 3-dioxygenase; immunosuppression; mammalian phylogeny

Funding

  1. Ministry of Science and Technology of China [2010CB945600, 2011DFA30630]
  2. Scientific Innovation Project of the Chinese Academy of Sciences [XDA01040107]
  3. International Cooperation and Exchanges NSFC [31010103908]
  4. Shanghai Municipal Key Projects of Basic Research [12JC1409200]

Ask authors/readers for more resources

Mammalian mesenchymal stem cells (MSCs) have been shown to be strongly immunosuppressive in both animal disease models and human clinical trials. We have reported that the key molecule mediating immunosuppression by MSCs is species dependent: indoleamine 2,3-dioxygenase (IDO) in human and inducible nitric oxide synthase (iNOS) in mouse. In the present study, we isolated MSCs from several mammalian species, each of a different genus, and investigated the involvement of IDO and iNOS during MSC-mediated immunosuppression. The characterization of MSCs from different species was by adherence to tissue culture plastic, morphology, specific marker expression, and differentiation potential. On the basis of the inducibility of IDO and iNOS by inflammatory cytokines in MSCs, the tested mammalian species fall into two distinct groups: IDO utilizers and iNOS utilizers. MSCs from monkey, pig, and human employ IDO to suppress immune responses, whereas MSCs from mouse, rat, rabbit, and hamster utilize iNOS. Interestingly, based on the limited number of species tested, the iNOS-utilizing species all belong to the phylogenetic clade, Glires. Although the evolutionary significance of this divergence is not known, we believe that this study provides critical guidance for choosing appropriate animal models for preclinical studies of MSCs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available